Valeant Pharmaceuticals International Inc has announced plans to acquire Sprout Pharmaceuticals Inc - just two days after Sprout received US regulatory approval to launch a new drug for low sexual desire in premenopausal women. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
